tiprankstipranks
Myriad Genetics (MYGN)
NASDAQ:MYGN
US Market

Myriad Genetics (MYGN) Income Statement

Compare
370 Followers

Myriad Genetics Income Statement

Last quarter (Q3 2024), Myriad Genetics's total revenue was $213.30M, an increase of 11.15% from the same quarter last year. In Q3, Myriad Genetics's net income was $-22.10M. See Myriad Genetics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Jun 20
Total Revenue
$ 753.20M$ 678.40M$ 690.60M$ 557.00M$ 851.10M
Gross Profit
$ 517.00M$ 476.40M$ 493.00M$ 378.80M$ 650.10M
Operating Expenses
$ 774.40M$ 600.10M$ 681.70M$ 653.30M$ 641.40M
Depreciation and Amortization
$ 61.90M$ 55.90M$ 62.80M$ 71.40M$ 73.00M
EBITDA
$ -186.10M$ -67.80M$ 14.10M$ -123.40M$ 86.10M
Operating Income
$ -257.40M$ -123.70M$ -48.70M$ -194.80M$ 7.60M
Other Income/Expenses
$ -4.80M$ -16.90M$ -8.40M$ -88.90M$ 100.00K
Pretax Income
$ -262.20M$ -140.60M$ -57.10M$ -283.70M$ 200.00K
Net Income
$ -263.30M$ -112.00M$ -27.20M$ -223.70M$ 4.60M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -3.18$ -1.39$ -0.35$ -2.99$ 0.06
Diluted EPS
$ -3.18$ -1.39$ -0.35$ -2.99$ 0.06
Weighted Average Shares Outstanding
82.80M 80.58M 77.71M 74.70M 73.50M
Weighted Average Shares Outstanding (Diluted)
82.80M 80.60M 78.00M 74.78M 76.00M
Currency in USD

Myriad Genetics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis